Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
Full-Text Search:
Chinese Journal of New Drugs
FQ: semimonthl
AD of Publication: China
Lanuage: English
ISSN: 1003-3734
CN: 11-2850/R
YP: 1992
Recommended Journals
International Journal of Pharmaceutical Research
World Notes on Antibiotics
World Clinical Drugs
Progress in Pharmaceutical Sciences
Journal of Pharmaceutical Practice
The Chinese Journal of Clinical Pharmacology
Chinese Journal of New Drugs
Chinese Journal of Pharmacology and Toxicology
Chinese Pharmaceutical Affairs
Chinese Journal of Medicinal Chemistry
Chinese Journal of Hospital Pharmacy
Chinese Journal of New Drugs
2012 -01
Influence of amidohydrolase gene copy number increasing in Actinoplanes utahensis strain on echinocandin B bioconversion efficiency LIU Ai-juan1,CHANG Qing1,2,LI Ji-an1,LU Liang1,CHEN Dai-jie1,SU Min1,3,SHAO Lei1(1 State Key Lab of New Drug and Pharmaceutical Process,Shanghai Institute of Pharmaceutical Industry, Shanghai 200437,China;2 School of Life Sciences,East China Normal University,Shanghai 200062,China; 3 Institute of Bioreactor Engineering,East China University of Science and Technology,Shanghai 200237,China)
Synthesis of dabigatran etexilate mesylate CHENG Qing-fang1,WANG Qi-fa2,LU Wei1,HUANG Fen-fen1,QIN Ya-juan1(1 School of Chemical Engineering,Huaihai Institute of Technology,Lianyungang 222005,China; 2 Jiangsu Marine Resources Development Research Institute,Lianyungang 222001,China)
Determination of plasma protein binding rate of schizonepetin in rats LIU Dong-liang1,GENG Ting1,SUN Yi1,YAO Wei-feng1,DING An-wei1,2,ZHANG Li1(1 Nanjing University of Chinese Medicine,Nanjing 210046,China;2 Jiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research,Nanjing 210046,China)
Summary of resources development and utilization and chemical composition studies of aquilariae lignum resinatum LIU Jun-min1,ZHAI Ming2(1 College of Chinese Materia Medica,Guangzhou University of TCM,Guangzhou 510006,China; 2 Medical College of Jiaying University,Meizhou 514031,China)
Review on the secondary metatolites from Phyllospongia sponges and their bioactivities WU Ze-hong,SHAO Chang-lun,WANG Chang-yun(Key Laboratory of Marine Drugs,Ministry of Education,School of Medicine and Pharmacy,Ocean University of China,Qingdao 266003,China)
A phase Ⅰ tolerance and safety study of Sailuotong capsule LI Tao1,LIU Hong-mei1,LU Yan1,JIA Zeng-qin1,XU Li1,GAO Rui1, LIU Jun-feng2,LIU Jian-xun1,TANG Xu-dong1(1 Xiyuan Hospital of China Academy of Chinese Medicine Sciences,Beijing 100091,China; 2 Shineway Pharmaceutical Co.,Ltd.,Shijiazhuang 051430,China)
Protective effects of phenylalanine dipeptide compounds Y101 on liver injury induced by CnoA in mice YU Shan1,3,XU Xue-yu2,LIANG Guang-yi3,HUANG Zheng-ming1(1 Department of Pharmacy,302 Hospital of PLA,Beijing 100039,China;2 Department of Pharmacy, 309 Hospital of PLA,Beijing 100091,China;3 Department of Guiyang College of Traditional Chinese Medicine,Guiyang 550002,China)
HPLC fingerprint and clustering analysis of lonicerae japonicae flos before and after sulfur-fumigated process MA Xiao-qing1,2,3,CAI Hao1,2,3,LIU Xiao1,2,3,LIU Jing-jing1,2,3, LI Song-lin4,ZONG Du-qiang1,CAI Bao-chang1,2,3,4(1 College of Pharmacy,2 Engineering Center of State Ministry of Education for Standardization of Chinese Medicine Processing,3 Key Laboratory of State Administration of TCM for Standardization of Chinese Medicine Processing,Nanjing University of Chinese Medicine,Nanjing 210029,China; 4 Nanjing Haichang Chinese Medicine Group Corporation,Nanjing 210061,China)
Comparison of bone metabolism in Chinese women with postmenopausal osteoporosis after alendronate sodium compressed tablets and alendronate enteric-coated tablets treatment LI Peng-mei1,LIU Xiao1,CUI Gang1,CHE Hui2,ZHANG Xiang-lin1(1 China-Japan Friendship Hospital,Beijing 100029,China;2 Institute for Drug and Instrument Control of PLA,Beijing 100071,China)
Literature analysis of 14 cases of adverse drug reactions induced by Xuebijing injection KONG Fei-fei1,SHEN Jie2,TAN Xing-qi1,GUO Liang-jun1(1 Department of Pharmacy,2 Department of Orthopaedics 6,The 98th Hospital of PLA,HuZhou 313000,China)
Binding characteristic of fully human anti-EGFR monoclonal antibody to EGFR in skin tissues of different species of animals PAN Dong-sheng1,LI Dan2,LIN Zhi1,SHEN Lian-zhong1,GAI Wen-lin2,LI Bo1(1 National Center for Safety Evaluation of Drug,National Institutes for Food and Drug Control,Beijing 100176,China;2 Cell Engineering Research Center,Chinese Academy of Medical Science & Peking Union Medical College,Beijing 100176,China)
Progress in tyrosine kinases targeted therapy of hepatocellular carcinoma WANG Ting-jin1,XI Ning1,2(1 Research Institute of HEC Group Co.,Ltd.,Dongguan 523850,China;2 Calitor Sciences, LLC,Thousand Oaks,California,CA 91319-9185,USA)
Application of expression proteomics in the research and development of anti-cancer drugs LU Jin-jian1,2,3,HUANG Ming-qing1,2,4,CHEN Xiu-ping1,2,WANG Yi-tao1,2(1 State Key Laboratory of Quality Research in Chinese Medicine,University of Macau,Macau 999078,China; 2 Institute of Chinese Medical Sciences,University of Macau,Macau 999078,China;3 College of Life Sciences,Zhejiang Chinese Medical University,Hangzhou 310053,China;4 College of Pharmacy, Fujian University of Traditional Chinese Medicine,Fuzhou 350108,China)
Effect of compound matrine injection on chemotherapeutic drug-induced liver injury SHI Yang,QIU Guang-xian,ZHOU Zhao-chun,CUI Shu-sheng(Department of Oncology,Central Hospital of Huangpu District,Shanghai 200002,China)
Clinical efficacy and mechanism of different doses of ulinastatin in patients after successful cardiopulmonary resuscitation ZHANG Ru-xin,ZHU Jie,WANG Si-wen(Department of Emergency,the Fourth Affiliated Hospital,China Medical University,Shenyang 110005,China)
A new antimetastatic breast cancer agent,eribulin mesylate YANG Qing(Chinese Journal of New Drugs Co.,Ltd.,Beijing 100120,China)
Study on improving the data protection system in China LIU Jin-jie,YANG Yue(Department of Administration,Shenyang Pharmaceutical University,Shenyang 110016,China)
Advances in clinical evaluation of the new lipid-altering agents from the perspective of drug administration guidance HUA Wei-li,XIE Song-mei,WANG Tao(Center for Drug Evaluation,State Food and Drug Administration,Beijing 100038,China)
A new drug for treating chronic lymphocytic leukemia,ofatumumab WANG Yan-ni(International Biomedical Communication,Maryland 21702,USA)
Clinical value and limitation of the open label extension phase of clinical trials ZHANG Nian-xian(Eisai China Inc.,Beijing 100024,China)
Protection of salidroside against lidamycin-induced cellular senescence in human fetal lung fibroblasts 2BS cells QIU Qiang1,MAO Gen-xiang2,SHEN Jia-jia2,DENG Hong-bin2,LI Dian-dong2,WANG Zhen2(1 Department of Nephrology,the General Hospital of PLA,Beijing 100853,China; 2 Department of Biochemistry,Institute of Medicinal Biotechnology,Beijing 100050,China)
Analysis of combined application of anti-hypertensive drugs WU Jiang1,TUO Ming-fu1,LUO Xiao-ke2,LI Bao-jun1(1 Department of Pharmacy,Pingliang City People's Hospital of Gansu,Pingliang 744000,China;2 Medical Device Division,Gansu Jingyuan Coal Industry Group Baiyin City General Hospital,Baiyin 730913,China)
2012 Issues:  [01] [02] [03] [04] [05] [06] [07] [08] [09] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24]
More Issues:   [1992]   [1993]   [1994]   [1995]   [1996]   [1997]   [1998]   [1999]   [2000]   [2001]   [2002]   [2003]   [2004]   [2005]   [2006]   [2007]   [2008]   [2009]   [2010]   [2011]   [2013]   [2014]   [2015]   [2016]   [2017]
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved